IRONWOOD PHARMACEUTICALS INC Quarterly Deferred Tax Assets, Valuation Allowance in USD from Q4 2010 to Q4 2023

Taxonomy & unit
us-gaap: USD
Description
Amount of deferred tax assets for which it is more likely than not that a tax benefit will not be realized.
Summary
Ironwood Pharmaceuticals Inc quarterly Deferred Tax Assets, Valuation Allowance history and growth rate from Q4 2010 to Q4 2023.
  • Ironwood Pharmaceuticals Inc Deferred Tax Assets, Valuation Allowance for the quarter ending December 31, 2023 was $85.6M, a 2704% increase year-over-year.
Deferred Tax Assets, Valuation Allowance, Quarterly (USD)
Deferred Tax Assets, Valuation Allowance, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q4 2023 $85.6M +$82.6M +2704% Dec 31, 2023 10-K 2024-02-16
Q4 2022 $3.06M -$1.16M -27.4% Dec 31, 2022 10-K 2024-02-16
Q4 2021 $4.21M -$391M -98.9% Dec 31, 2021 10-K 2023-02-16
Q4 2020 $395M -$35.2M -8.19% Dec 31, 2020 10-K 2022-02-18
Q4 2019 $430M -$29.1M -6.34% Dec 31, 2019 10-K 2021-02-17
Q4 2018 $459M +$80.6M +21.3% Dec 31, 2018 10-K 2020-02-13
Q4 2017 $379M -$95.8M -20.2% Dec 31, 2017 10-K 2019-02-25
Q4 2016 $475M +$66.3M +16.3% Dec 31, 2016 10-K 2018-02-22
Q4 2015 $408M +$40.7M +11.1% Dec 31, 2015 10-K 2017-02-22
Q4 2014 $367M +$58.7M +19% Dec 31, 2014 10-K 2016-02-19
Q4 2013 $309M +$106M +52.1% Dec 31, 2013 10-K 2015-02-18
Q4 2012 $203M +$34.8M +20.7% Dec 31, 2012 10-K 2014-02-07
Q4 2011 $168M +$20.3M +13.8% Dec 31, 2011 10-K 2013-02-21
Q4 2010 $148M Dec 31, 2010 10-K 2012-02-29
* An asterisk sign (*) next to the value indicates that the value is likely invalid.